⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
Mitochonic Acid-5 (MA-5)
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-09-14 — MA-5 attenuates disease-associated transcriptomic aging and pathological microglial states in Gaucher disease.: Preclinical study in Gaucher disease mouse models and patient-iPSC-derived microglia: MA-5 preserved mitochondrial cristae, blocked mtDNA-driven cGAS–STING/NLRP3 inflammation, suppressed galectin-3, extended survival, and reversed disease-associated transcriptomic aging signatures in brain and liver (animal-model + mechanism). [animal-model] (novelty: 3)
Open questions
Related
Contributing findings
MA-5 attenuates disease-associated transcriptomic aging and pathological microglial states in Gaucher disease.
14-sep-2026
novelty 3
per-area 3
strengthens